Application of AMT-PET has also been studied in brain tumor imaging: AMT is accumulated in various brain tumors, and kinetic AMT-PET parameters are able to differentiate various brain tumor types, assess glioma proliferative activity, and estimate IDO and tryptophan 2,3-dioxygenase expression in both gliomas and meningiomas [27–32]. The gene discussed is IDO1; the disease is central nervous system cancer.